Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The pro-inflammatory cytokine cascade refers to a complex sequence of immune signaling events involving the release and action of specific cytokines that promote inflammation. Cytokines are small, secreted proteins that act as key modulators in the immune system, particularly during responses to infection, injury, or other harmful stimuli. The cascade is characterized by the rapid production and amplification of pro-inflammatory cytokines—primarily interleukins (such as IL-1β and IL-6), tumor necrosis factor-alpha (TNF-α), interferon-gamma (IFN-γ), and others—which coordinate the recruitment, activation, and proliferation of various immune cells at sites of tissue damage or infection. An overactive pro-inflammatory cytokine cascade can result in a "cytokine storm," where positive feedback leads to massive systemic inflammation. Targeting elements within this cascade—such as blocking specific pro-inflammatory cytokines or their receptors—is an established therapeutic strategy for autoimmune diseases and has been explored for managing severe viral infections marked by hyperinflammatory states.
Blocking specific pro-inflammatory cytokines or their receptors
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Pro-inflammatory Cytokine Cascade.